Dayal Molina B, Gindoff Paul R, Sarhan Abbaa, Dubey Anil, Peak Douglas, Frankfurter David
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, The George Washington University, Washington, District of Columbia 20037, USA.
Fertil Steril. 2009 Jan;91(1):101-5. doi: 10.1016/j.fertnstert.2007.11.033. Epub 2008 Feb 4.
To evaluate the impact on the rates of clinical pregnancy and live birth of polyploidy after intracytoplasmic sperm injection (ICSI).
Retrospective cohort study.
University-based IVF center.
PATIENT(S): One hundred forty-three patients undergoing their first IVF-embryo transfer cycle requiring ICSI.
INTERVENTION(S): None.
MAIN OUTCOME MEASURE(S): Patients were divided into two groups on the basis of the proportion of post-ICSI triploid fertilization that was observed at the time of fertilization assessment: group 1 included patients with <or=20% three-pronuclear (3PN) zygotes, and group 2 included patients with >20% 3PN zygotes. The primary outcomes compared between groups were pregnancy and implantation rates; secondary outcome measures included clinical-pregnancy rate and live-birth rate per embryo transfer.
RESULT(S): Pregnancy, implantation, clinical-pregnancy, and live-birth rates were significantly higher in the cohort of patients who had <or=20% of embryos appearing triploid, compared with the group who had >20% of zygotes appearing triploid (relative risk [RR] for pregnancy, 2.4 [95% confidence interval {CI}, 1.22-4.77]; RR for implantation, 2.6 [95% CI, 1.17-5.56]; RR for clinical pregnancy, 2.8 [95% CI, 1.16-6.85]; and RR for live birth, 2.6 [95% CI, 1.06-6.38]). The proportion of 3PN zygotes after ICSI had a statistically significant inverse relationship to clinical-pregnancy rate.
CONCLUSION(S): The proportion of triploid zygotes after ICSI serves as a negative prognostic indicator for IVF cycle outcome. This finding suggests that triploidy proportion is a surrogate marker of oocyte competence that represents the integrity of the oocytes in the entire recruited cohort. Such findings therefore may influence recommendations for embryo transfer number and freezing of supernumerary embryos.
评估卵胞浆内单精子注射(ICSI)后多倍体对临床妊娠率和活产率的影响。
回顾性队列研究。
大学附属体外受精中心。
143例首次接受需要ICSI的体外受精-胚胎移植周期的患者。
无。
根据受精评估时观察到的ICSI后三倍体受精比例,将患者分为两组:第1组包括三原核(3PN)合子比例≤20%的患者,第2组包括3PN合子比例>20%的患者。两组之间比较的主要结局是妊娠率和着床率;次要观察指标包括每次胚胎移植的临床妊娠率和活产率。
与3PN合子比例>20%的组相比,3PN合子比例≤20%的胚胎队列的妊娠率、着床率、临床妊娠率和活产率显著更高(妊娠的相对风险[RR]为2.4[95%置信区间{CI},1.22 - 4.77];着床的RR为2.6[95%CI,1.17 - 5.56];临床妊娠的RR为2.8[95%CI,1.16 - 6.85];活产的RR为2.6[95%CI,1.06 - 6.38])。ICSI后3PN合子的比例与临床妊娠率呈统计学显著负相关。
ICSI后三倍体合子的比例是体外受精周期结局的负性预后指标。这一发现表明,三倍体比例是卵母细胞能力的替代标志物,代表了整个募集队列中卵母细胞的完整性。因此,这些发现可能会影响胚胎移植数量和多余胚胎冷冻的建议。